Member Info for Energyshares

Natalie Cook in charge of Christie trial posting a Job on twitter for a Senior Clinical Research Fellow, Experimental Cancer Medicine Team
Closing date 14th December.

We seek an ambitious, innovative individual to provide medical support to the consultants by primarily acting as co-investigator on a growing portfolio of Phase I clinical trials.

next-generation chemotherapy trials

You will be expected to attend Safety Review Committee meetings (usually remotely) to discuss trial patients.

The remit of the ECMT is to undertake cutting edge research in developing new therapeutics & conducting translational cancer research. Phase I trials are an important first step in the drug development process & are not only designed to test the safety & tolerability of novel agents but interrogate new drug formulations, combinations, pharmacokinetics & pharmacodynamics.

Is it us…. :)

https://beta.jobs.nhs.uk/candidate/jobadvert/C9413-22-5697

That’s when the trial started this wasn’t in a RNS.

I’d be a bit worried if they announced this now :):):)

Our founder and Managing Director, Sue Keeler, brings 30 years’ experience in dealing with these challenges. In her role as global head of Clinical Samples Sciences for AstraZeneca and by establishing an external laboratory service for a leading central lab, Sue recognised that the way in which we manage clinical samples needed to change in order to meet the ever modifying requirements of the adaptive trial.

And so Colibri Scientific was born.

They know what they are doing.. onwards Avacta

Looks like Colibri scientific have been helping Avacta with the AVA6000 trial

We are very excited to announce that we have been selected by Avacta Life Sciences to enter a strategic relationship for the provision of global sample management services to support Avacta’s clinical development portfolio.
We are delighted to be working with Avacta Life Sciences, Therapeutics Division and are very much looking forward to a successful partnership.

This isn’t the Diagnostic division but the Therapeutics division.

“Global sample management”

This link announces partnership.

https://colibriscientific.co.uk/wp-content/uploads/2021/11/The-Hummingbird-November-2021.pdf

Click on this link and watch the video clip about clinical trial sample operations.

https://colibriscientific.co.uk/

We are nearly there GLA All.

Yes paid in cash for Launch,but they are cash generative and this taking a lot of pressure off the top line.

I expect news before Christmas otherwise market will start to get nervous.

Come on Big Al don’t be the grinch just a two word RNS will do “It Works”

Avacta’s acquisition of Launch Diagnostics already paying off.

All the payroll from the diagnostics division is now covered with the Therapeutics division about to announce some licences the future looks bright for Avacta.

Launch has a foot in EU and their French division will win plenty of contracts.

Not a bad award from the EU plenty more to come.

https://ted.europa.eu/udl?uri=TED:NOTICE:646776-2022:TEXT:EN:HTML&src=0

Name and address of the contractor
Official name: launch Diagnostics France SAS
Postal address: 6, avenue Franklin D Roosevelt
Town: Paris
NUTS code: FR10 Ile-de-France
Postal code: 75008
Country: France
The contractor is an SME: yes
V.2.4)
Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: 433 125.00 EUR

GLA

Avacta running a very tight ship 81 employees on LinkedIn and the only posts are likes about White City & Launch acquisition.

They know we are watching for clues.
Silence is golden this next RNS is going to blow the bloody doors off.

https://m.youtube.com/watch?v=8g_GeQR8fJo

Rah & Rippers top ticks for week LSE

RAH0084 624.96
hopingforbags 604.56
HeresHopin 565.46
MrRipley 557.35
magmanus_49 443.48

While we wait for PK data
Avacta have some experience of collecting PK data from back in 2017.

Improving Pharmacokinetic Assays in a Regulatory Bioanalysis Setting

Applying Affimers
Dr Amanda Nicholl at Avacta Life Sciences expresses the fundamentality of pharmacokinetic assay results in the phases of drug development and how to increase the effectiveness and efficacy of antibody drug development

http://www.samedanltd.com/magazine/12/issue/296/article/4898

Tree Shake
Hold on to those golden tickets

With the Newcastle hospital coming on line yesterday,I’m even more relaxed and chilled about my holding in Avacta.
If FDA and Safety Committee and all the clues Avacta keep putting out isn’t enough.
Other shots
TMac
Point
LG Chem

But another massive tick is Daewoong Pharmaceutical CEO Jeon Seng-ho who has actually made himself CEO of a newly formed JV start up Affyxell with Avacta.

This guy is one busy man he runs Daewoong Pharmaceutical Co which is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to grow fivefold in seven years given that it logged revenue of 1 trillion won in 2020. 

If you run a billion dollar company but your giving time to be CEO and sit on the board of a start up.
That’s confidence….

GLA hold for gold :):):)

Good find Burton

Jive
I never mentioned cohorts,just hospitals
If you look on the page I posted each version adds another hospital.

On this page,each time they have changed the version, it’s when a new hospital starts recruiting.

But one thing which is a positive the primary completion and study completion dates have not changed at all.
Primary completion May 31st 2023
Study completion June 30th 2023

And the FDA have monitoring the trial from version one.

https://clinicaltrials.gov/ct2/history/NCT04969835

Version 1, non recruiting

Version 2, just one recruiting
Royal Marsden

Version 3, two recruiting
Royal Marsden,Leeds

Version 4, three recruiting
Royal Marsden,Leeds, Manchester

Version 5, four recruiting
Royal Marsden,Leeds, Manchester, Glasgow

Version 6, five recruiting

Royal Marsden,Leeds, Manchester,Glasgow, Newcastle

Zoom, 80 number for the whole trial.
That text has been there from start of trial,
only thing changed today was Newcastle recruiting.

GLA

Great link gadgie
Ruth Plummer expertise Adult sarcoma
ODD sarcoma …

https://www.medifind.com/doctors/ruth-plummer/333311206

I was typing out and posted seen your post crowfoot Snap back ;)

Trial still going or P1b great news….

Clinical trials site updated today
Newcastle now recruiting.

P1b let’s go
It Works
GLA

https://clinicaltrials.gov/ct2/show/NCT04969835

Swoop reading your post history is enough

gmcc

I wouldn’t bother with him, he is just a troll
All LTH know they can move to P1b and patents are all covered.
Just another pair of nob trolls Teeth has sent over.